Literature DB >> 30121183

Social vs. non-social measures of learning potential for predicting community functioning across phase of illness in schizophrenia.

Peter E Clayson1, Robert S Kern2, Keith H Nuechterlein3, Barbara J Knowlton4, Carrie E Bearden3, Tyrone D Cannon5, Alan P Fiske6, Livon Ghermezi7, Jacqueline N Hayata7, Gerhard S Hellemann7, William P Horan2, Kimmy Kee8, Junghee Lee2, Kenneth L Subotnik7, Catherine A Sugar7, Joseph Ventura7, Cindy M Yee3, Michael F Green2.   

Abstract

Studies demonstrate that dynamic assessment (i.e., learning potential) improves the prediction of response to rehabilitation over static measures in individuals with schizophrenia. Learning potential is most commonly assessed using neuropsychological tests under a test-train-test paradigm to examine change in performance. Novel learning potential approaches using social cognitive tasks may have added value, particularly for the prediction of social functioning, but this area is unexplored. The present study is the first to investigate whether patients with schizophrenia demonstrate social cognitive learning potential across phase of illness. This study included 43 participants at clinical high risk (CHR), 63 first-episode, and 36 chronic schizophrenia patients. Assessment of learning potential involved test-train-test versions of the Wisconsin Card Sorting Test (non-social cognitive learning potential) and the Facial Emotion Identification Test (social cognitive learning potential). Non-social and social cognition pre-training scores (static scores) uniquely predicted concurrent community functioning in patients with schizophrenia, but not in CHR participants. Learning potential showed no incremental explanation of variance beyond static scores. First-episode patients showed larger non-social cognitive learning potential than CHR participants and were similar to chronic patients; chronic patients and CHR participants were similar. Group differences across phase of illness were not observed for social cognitive learning potential. Subsequent research could explore whether non-social and social cognitive learning potential relate differentially to non-social versus social types of training and rehabilitation. Published by Elsevier B.V.

Entities:  

Keywords:  Dynamic assessment; FEIT; Learning potential; Schizophrenia; Social cognition; WCST

Mesh:

Year:  2018        PMID: 30121183      PMCID: PMC6377348          DOI: 10.1016/j.schres.2018.07.046

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  57 in total

1.  Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.

Authors:  Larry J Seidman; Anthony J Giuliano; Eric C Meyer; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Bruce K Christensen; Keith Hawkins; Robert Heaton; Richard S E Keefe; Robert Heinssen; Barbara A Cornblatt
Journal:  Arch Gen Psychiatry       Date:  2010-06

2.  Learning (potential) and social functioning in schizophrenia.

Authors:  Frank M J Woonings; Martin T Appelo; H Kluiter; Cees J Slooff; Robert J van den Bosch
Journal:  Schizophr Res       Date:  2003-02-01       Impact factor: 4.939

Review 3.  The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis.

Authors:  Anne-Kathrin J Fett; Wolfgang Viechtbauer; Maria-de-Gracia Dominguez; David L Penn; Jim van Os; Lydia Krabbendam
Journal:  Neurosci Biobehav Rev       Date:  2010-07-08       Impact factor: 8.989

4.  The "Right Stuff" Revisited: What Have We Learned About the Determinants of Daily Functioning in Schizophrenia?

Authors:  Michael F Green; Katiah Llerena; Robert S Kern
Journal:  Schizophr Bull       Date:  2015-03-07       Impact factor: 9.306

5.  Neurocognitive predictors of work outcome in recent-onset schizophrenia.

Authors:  Keith H Nuechterlein; Kenneth L Subotnik; Michael F Green; Joseph Ventura; Robert F Asarnow; Michael J Gitlin; Cindy M Yee; Denise Gretchen-Doorly; Jim Mintz
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

Review 6.  Cognition at illness onset as a predictor of later functional outcome in early psychosis: systematic review and methodological critique.

Authors:  Kelly Allott; Ping Liu; Tina-Marie Proffitt; Eoin Killackey
Journal:  Schizophr Res       Date:  2010-12-15       Impact factor: 4.939

Review 7.  Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS.

Authors:  Michael F Green; Robert S Kern; Robert K Heaton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

8.  Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients.

Authors:  William P Horan; Michael F Green; Michael DeGroot; Alan Fiske; Gerhard Hellemann; Kimmy Kee; Robert S Kern; Junghee Lee; Mark J Sergi; Kenneth L Subotnik; Catherine A Sugar; Joseph Ventura; Keith H Nuechterlein
Journal:  Schizophr Bull       Date:  2011-03-07       Impact factor: 9.306

9.  An Individualized Risk Calculator for Research in Prodromal Psychosis.

Authors:  Tyrone D Cannon; Changhong Yu; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Robert Heinssen; Clark D Jeffries; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Michael W Kattan
Journal:  Am J Psychiatry       Date:  2016-07-01       Impact factor: 18.112

10.  The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with first-episode psychosis: a 3 year longitudinal study.

Authors:  Rosa Ayesa-Arriola; José Manuel Rodríguez-Sánchez; Rocío Pérez-Iglesias; César González-Blanch; Gema Pardo-García; Rafael Tabares-Seisdedos; Jose L Vázquez-Barquero; Benedicto Crespo-Facorro
Journal:  Psychiatry Res       Date:  2013-02-10       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.